Abstracts tagged "systemic lupus erythematosus (SLE) and prognostic factors"

Abstract Number: 1584 • 2019 ACR/ARP Annual Meeting
Factors Associated with Accrual of Damage over Time in Patients with SLE: Results from a Multinational Latin American Cohort
Milena Mimica¹, Oslando Padilla ², Felipe Aguilera ³, Fernando Cavalcanti ⁴, Eduardo Borba ⁵, Marlene Guibert-Toledano ⁶, Rosa Chacon-Diaz ⁷, Gloria Vasquez ⁸, Guillermo Pons-Estel ⁹, Mario Cardiel ¹⁰, Oscar Neira ¹¹, Mary-Carmen Amigo ¹², Eloisa Bonfa ¹³, Graciela Alarcón ¹⁴, Bernardo A. Pons-Estel ¹⁵ and Loreto Massardo ¹⁶, ¹Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia. Universidad San Sebastián, Santiago, Chile., Santiago, Region Metropolitana, Chile, ²Pontificia Universidad Católica de Chile, Santiago, Region Metropolitana, Chile, ³Universidad San Sebastián, Santiago, Region Metropolitana, Chile, ⁴Hospital das Clínicas da Universidade Federal de Pernambuco, Recife, Brazil, ⁵Rheumatology Division, Hospital das Clinicas, Faculdade de Medicina da Universidade de Sao Paulo (HCFMUSP), Sao Paulo, Brazil., Sao Paulo, Brazil, ⁶Servicio Nacional de Reumatología, Centro de Investigaciones Médico Quirúrgicas (CIMEQ), La Habana, Cuba, ⁷Servicio de Reumatología, Policlínica Méndez Gimón, Caracas, Venezuela., Caracas, Venezuela, ⁸University of Antioquia, Medellin, Antioquia, Colombia, ⁹Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina, ¹⁰Centro de Investigación Clínica de Morelia, SC, Morelia, México., Morelia, Mexico, ¹¹Sección Reumatología, Hospital del Salvador. Universidad de Chile. Unidad de Reumatología. Clínica Alemana de Santiago, Facultad de Medicina Clínica Alemana, Universidad del Desarrollo., Santiago, Chile, Santiago, Chile, ¹²Servicio de Reumatología, Centro Médico ABC, Ciudad de México, México., Mexico, Mexico, ¹³Rheumatology Division, Hospital das Clinicas, Faculdade de Medicina da Universidade de Sao Paulo (HCFMUSP), Sao Paulo, Brazil., Sao Paulo, Sao Paulo, Brazil, ¹⁴University of Alabama at Birmingham, Birmingham, ¹⁵Centro Regional de Enfermedades Autoinmunes y Reumáticas (CREAR), Grupo Oroño, Rosario, Rosario, Argentina, ¹⁶Centro de Biología Celular y Biomedicina, Facultad de Medicina y Ciencia. Universidad San Sebastián, Santiago, Chile., Santiago, Chile
Background/Purpose: Patients with Systemic Lupus Erythematosus (SLE) are at risk of accumulating damage, having an impaired quality of life and experiencing a premature death. The…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].